"Dr. Keith Marcus is a top facial plastic surgeon and has helped thousands of patients achieve youthful, natural-looking results through the delicate art of facial plastic surgery. As a double board certified facial plastic surgeon, Dr. Marcus is known for delivering superb results in both rhinoplasty and facelifts, among other procedures."

During the past decade, Marcus Facial Plastic Surgery conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Marcus Facial Plastic Surgery" are "Chin Augmentation" (1 trials), "Chin Retrusion" (1 trials), "Glabellar Lines" (1 trials), "Infraorbital Hollows" (1 trials) and "Lateral Canthal Lines" (1 trials). Many other conditions were trialed in "Marcus Facial Plastic Surgery" in a lesser frequency.

Most popular intervention types in "Marcus Facial Plastic Surgery" are "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Restylane Defyne" (1 trials), "Restylane-L®" (1 trials) and "botulinum toxin neuromodulator" (1 trials). Other intervention names were less common.

The vast majority of trials in "Marcus Facial Plastic Surgery" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Marcus Facial Plastic Surgery". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Marcus Facial Plastic Surgery, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Marcus Facial Plastic Surgery, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".